Phase I trial of docetaxel and short infusion Gemcitabine given every two weeks for advanced solid tumors

被引：0
|
作者：
Davis, TH
Rigas, JR
Maurer, LH
Pipas, JM
Obrocea, M
Tretter, CP
Smith, EL
Meyer, L
Hammond, S
机构：
[1] Norris Cotton Canc Ctr, Lebanon, NH USA
[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
642P
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [31] A phase I clinical and pharmacokinetic trial of oxaliplatin and irinotecan (CPT-11) given every two weeks to patients with refractory solid tumors.
    Rothenberg, ML
    McKinney, J
    Hande, KR
    Dorminy, C
    Berlin, H
    Boeing, A
    Johnson, DH
    Purvis, JD
    CLINICAL CANCER RESEARCH, 1999, 5 : 3853S - 3853S
  • [32] A phase I study of the safety and pharmacokinetics (PK) of XMT-1001 given as an intravenous (IV) infusion once every three weeks to patients with advanced solid tumors
    Sausville, E.
    Garbo, L.
    Weiss, G. J.
    Anthony, S.
    Shkolny, D.
    Yurkovetskiy, A. V.
    Bethune, C.
    Fram, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] Phase I trial of weekly and every 3 weeks ixabepilone (Ix) and sunitinib (S) in advanced solid tumors (STs).
    Kittaneh, M.
    Montero, A. J.
    Kovacs, K.
    Amado, V. D. Guardiola
    Flores, A. M.
    Ferrell, A.
    Vulfovich, M.
    Pegram, M. D.
    Benedetto, P. W.
    Lima, C. M. S. Rocha
    Merchan, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
    Syma Iqbal
    Heinz-Josef Lenz
    David R. Gandara
    Stephen I. Shibata
    Susan Groshen
    Timothy W. Synold
    Edward M. Newman
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 85 - 91
  • [35] A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
    Iqbal, Syma
    Lenz, Heinz-Josef
    Gandara, David R.
    Shibata, Stephen I.
    Groshen, Susan
    Synold, Timothy W.
    Newman, Edward M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 85 - 91
  • [36] A Phase I Trial of Bexarotene in Combination With Docetaxel in Patients With Advanced Solid Tumors
    Malik, Shakun M.
    Collins, Brian
    Pishvaian, Michael
    Ramzi, Pari
    Marshall, John
    Hwang, Jimmy
    CLINICAL LUNG CANCER, 2011, 12 (04) : 231 - 236
  • [37] Phase I trial of intoplicine (RP 60475) administered as a 72 h infusion every 3 weeks in patients with solid tumors
    Newman, RA
    Kim, J
    Newman, BM
    Bruno, R
    Bayssas, M
    Klink-Alakl, M
    Pazdur, R
    ANTI-CANCER DRUGS, 1999, 10 (10) : 889 - 894
  • [38] A phase I trial of docetaxel and gemcitabine in patients with advanced cancer
    Rischin, D
    Boyer, M
    Smith, J
    Millward, M
    Michael, M
    Bishop, J
    Zalcberg, J
    Davison, J
    Emmett, E
    McClure, B
    ANNALS OF ONCOLOGY, 2000, 11 (04) : 421 - 426
  • [39] A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
    William Schelman
    Sherry Morgan-Meadows
    Howard Bailey
    Kyle Holen
    James P. Thomas
    Jens Eickhoff
    Heidi Brandon
    Kate Oliver
    Dona Alberti
    George Wilding
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 727 - 733
  • [40] Gemcitabine and carboplatin combination in advanced solid tumors: A phase I trial.
    Tassinari, D
    Pasini, G
    Arcangeli, V
    Panzini, I
    Drudi, G
    Gianni, L
    Oliverio, G
    Sartori, S
    Fochessati, F
    ANNALS OF ONCOLOGY, 2000, 11 : 141 - 141
12345